Standout Papers

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Gro... 2004 2026 2011 2018 683
  1. Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors (2004)
    Dirk Strumberg, Heike Richly et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 12 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Tumour vasculature at single-cell resolution
2024 StandoutNature
Bacteria hijack a meningeal neuroimmune axis to facilitate brain invasion
2023 StandoutNature
2 intermediate papers

Works of R. Voigtmann being referenced

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors
2004 Standout
Plasma levels of 15-keto-13,14-dihydro-prostaglandin E2 in patients with bronchogenic carcinoma
1984

Author Peers

Author Last Decade Papers Cites
R. Voigtmann 975 207 589 508 38 1.8k
Mary M. Sugrue 1242 155 916 463 48 2.2k
Heike Richly 1135 185 1059 719 56 2.3k
N. Schleucher 789 160 591 601 32 1.6k
Jane Robertson 1263 118 807 500 56 2.0k
Harm Sinnige 1595 420 530 557 29 2.1k
Kiyoshi Okamoto 503 198 589 324 52 1.7k
Ki Y. Chung 1601 199 606 696 61 2.3k
Dana T. Aftab 869 75 794 567 45 1.8k
Ramasamy Jagadeeswaran 593 152 1118 726 46 2.2k
Frank A. Scappaticci 1382 102 1193 842 38 2.8k

All Works

Loading papers...

Rankless by CCL
2026